Fibroblast growth factor-2 is a sputum remodeling biomarker of severe asthma

Journal of Asthma

Volumn 51, Issue 2, 2014, Pages 119-126

  Bissonnette, Élyse Y ^a   Madore, Anne Marie ^b   Chakir, Jamila ^a   Laviolette, Michel ^a   Boulet, Louis Philippe ^a   Hamid, Qutayba ^c   Bergeron, Céline ^d   Maghni, Karim ^e   Laprise, Catherine ^b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

FEV1 FVC ratio; FGF 2; MMP 1; Remodeling; Severity

Indexed keywords

BIOLOGICAL MARKER; COLLAGENASE 3; CONNECTIVE TISSUE GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; NEUTROPHIL COLLAGENASE; PROCOLLAGEN C PROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AIRWAY REMODELING; ARTICLE; ASTHMA; BRONCHUS BIOPSY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG FUNCTION TEST; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL; ONSET AGE; SPUTUM; SPUTUM ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASTHMA; BIOLOGICAL MARKERS; BRONCHI; EOSINOPHILS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LEUKOCYTE COUNT; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SPUTUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1; YOUNG ADULT;

EID: 84894410574     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2013.860164     Document Type: Article

References (35)

1. Holgate ST. Pathogenesis of asthma. Clin Exp Allergy 2008;38: 872-897
2. Masoli M, Fabian D, Holt S, Beasley R. Global burden of asthma. Developped for the Global Initiative for Asthma: Medical Research Institute of New-Zealand, Wellintgon, New Zealand and University of Southampton, Southampton, United Kingdom; 2004. Available at: Http://www.ginasthma.com/ReportItem.asp?l1 2&l22&intId94 [last accessed Jun 2013].
3. Wenzel SE. Asthma phenotypes: The evolution from clinical to molecular approaches. Nat Med 2012;18:716-725
4. Wadsworth S, Sin D, Dorscheid D. Clinical update on the use of biomarkers of airway inflammation in the management of asthma. J Asthma Allergy 2011;4:77-86
5. Szefler SJ, Wenzel S, Brown R, Erzurum SC, Fahy JV, Hamilton RG, Hunt JF, et al. Asthma outcomes: Biomarkers. J Allergy Clin Immunol 2012;129:S9-S23
6. Diamant Z, Boot JD, Mantzouranis E, Flohr R, Sterk PJ, Gerth van Wijk R. Biomarkers in asthma and allergic rhinitis. Pulm Pharmacol Ther 2010;23:468-481
7. Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol 2011;128:451-62; quiz 63-64
8. Bosse Y, Rola-Pleszczynski M. FGF2 in asthmatic airway-smoothmuscle-cell hyperplasia. Trends Mol Med 2008;14:3-11
9. Royce SG, Cheng V, Samuel CS, Tang ML. The regulation of fibrosis in airway remodeling in asthma. Mol Cell Endocrinol 2012; 351:167-175
10. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2012. Available at: Http://www. ginasthma.org/ [last accessed Jun 2013].
11. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, et al. Indices of airway inflammation in induced sputum: Reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308-317
12. Hackett TL. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. Curr Opin Allergy Clin Immunol 2012;12:53-59
13. Chakir J, Hamid Q, Bosse M, Boulet LP, Laviolette M. Bronchial inflammation in corticosteroid-sensitive and corticosteroid-resistant asthma at baseline and on oral corticosteroid treatment. Clin Exp Allergy 2002;32:578-582
14. Series F, Chakir J, Boivin D. Influence of weight and sleep apnea status on immunologic and structural features of the uvula. Am J Respir Crit Care Med 2004;170:1114-1119
15. Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008;63:1046-1051
16. Short PM, Lipworth SI, Lipworth BJ. Relationships between airway hyperresponsiveness, inflammation, and calibre in asthma. Lung 2011;189:493-497
17. James AL, Bai TR, Mauad T, Abramson MJ, Dolhnikoff M, McKay KO, Maxwell PS, et al. Airway smooth muscle thickness in asthma is related to severity but not duration of asthma. Eur Respir J 2009; 34:1040-1045
18. Kanazawa H, Yoshikawa T. Up-regulation of thrombin activity induced by vascular endothelial growth factor in asthmatic airways. Chest 2007;132:1169-1174
19. Redington AE, Roche WR, Madden J, Frew AJ, Djukanovic R, Holgate ST, Howarth PH. Basic fibroblast growth factor in asthma: Measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol 2001;107:384-387
20. Shute JK, Solic N, Shimizu J, McConnell W, Redington AE, Howarth PH. Epithelial expression and release of FGF-2 from heparan sulphate binding sites in bronchial tissue in asthma. Thorax 2004;59:557-562
21. Yum HY, Cho JY, Miller M, Broide DH. Allergen-induced coexpression of bFGF and TGF-beta1 by macrophages in a mouse model of airway remodeling: BFGF induces macrophage TGF-beta1 expression in vitro. Int Arch Allergy Immunol 2011; 155:12-22
22. Yang YC, Zhang N, Van Crombruggen K, Hu GH, Hong SL, Bachert C. Transforming growth factor-beta1 in inflammatory airway disease: A key for understanding inflammation and remodeling. Allergy 2012;67:1193-1202
23. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989;58: 575-606
24. Bentley JK, Hershenson MB. Airway smooth muscle growth in asthma: Proliferation, hypertrophy, and migration. Proc Am Thorac Soc 2008;5:89-96
25. Hassan M, Jo T, Risse PA, Tolloczko B, Lemiere C, Olivenstein R, Hamid Q, Martin JG. Airway smooth muscle remodeling is a dynamic process in severe long-standing asthma. J Allergy Clin Immunol 2010;125:1037-1045e3
26. Kaminska M, Foley S, Maghni K, Storness-Bliss C, Coxson H, Ghezzo H, Lemière C, et al. Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol 2009;124:45-51 e1-e4
27. Gueders MM, Foidart JM, Noel A, Cataldo DD. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: Potential implications in asthma and other lung diseases. Eur J Pharmacol 2006;533:133-144
28. Cataldo DD, Gueders M, Munaut C, Rocks N, Bartsch P, Foidart JM, Noel A, Louis R. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. Lab Invest 2004;84:418-424
29. Huang CD, Lin SM, Chang PJ, Liu WT, Wang CH, Liu CY, Lin HC, et al. Matrix metalloproteinase-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population. J Asthma 2009;46:41-46
30. Wenzel SE, Balzar S, Cundall M, Chu HW. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: Association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol 2003;111:1345-1352
31. Culpitt SV, Rogers DF, Traves SL, Barnes PJ, Donnelly LE. Sputum matrix metalloproteases: Comparison between chronic obstructive pulmonary disease and asthma. Respir Med 2005;99:703-710
32. Obase Y, Rytila P, Metso T, Pelkonen AS, Tervahartiala T, Turpeinen M, Mäkelä M, et al. Effects of inhaled corticosteroids on metalloproteinase-8 and tissue inhibitor of metalloproteinase-1 in the airways of asthmatic children. Int Arch Allergy Immunol 2010; 151:247-254
33. Chaudhuri R, McSharry C, Brady J, Donnelly I, Grierson C, McGuinness S, Jolly L, et al. Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: Relationship to disease severity. J Allergy Clin Immunol 2012;129: 655-663 e8
34. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25-29
35. Woolhouse IS, Bayley DL, Stockley RA. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax 2002; 57:667-671